Global demand for excellent quantitative test or quantitative point of care testing is constantly increasing. This is not surprising given the aspirational goal of ‘Personalised Healthcare’, where patients are matched with the right treatment at the right time using their individual biomarker profiles.
Quantitative tests use complex mathematical or statistical modelling to enable a systematic, rigorous, and empirical investigation.
The main strength of quantitative tests is being able to produce accurate and reliable patient results in an efficient manner. It means that the interventions that can maximise a patient’s quality and quantity of life can be effectively identified and applied, quickly in order to benefit both the patient and the strain on the healthcare system. One of the benefits of evidence-based quantitative tests in healthcare is recognising which procedures are best for treating diseases.
The key measures of analytical performance for most quantitative Point of Care testing are accuracy, or trueness of the result, and precision, or reproducibility of the measurement.
To work in conjunction with AgPlus Diagnostics’ proven sensitive assay development service, we are proud to be launching our very own diagnostic reader. The Agilis Reader provides a robust solution for gathering fast and quantitative data which is fully connected with a global network.
The AgPlus platform offers fully quantitative tests for the analysis of multiple analytes from a single sample in a truly portable diagnostic device. The system has been developed in line with required ISO standards and complies with IVDR to ensure development partners can easily integrate into their regulatory compliance systems for approval of use.
The multi-application capability of the AgPlus platform will see it meeting many challenges faced by the healthcare industry such as devolved care, remote healthcare, an aging population, triage and emergency testing in hospitals, and increased occurrence of infectious diseases.
Our technology platform will decrease wait times in clinics and hospitals and have an economic benefit for healthcare systems and increase patient wellbeing due to providing instant results, speeding up the treatment process. This will also aid healthcare professionals in prescribing appropriate medication and minimise invasive healthcare procedures. It also has huge benefits in the fight against antimicrobial resistance which sees the resistance to anti-biotics increasing across the world.
Antimicrobial resistance happens when germs like bacteria and fungi develop the ability to defeat the drugs designed to kill them. That means the germs are not killed and continue to grow. Resistant infections can be difficult, and sometimes impossible, to treat. So an essential mission of ours at AgPlus is to prevent this from happening.
If you are interested in working with AgPlus Diagnostics as a highly experienced partner, to develop a quantitative test together, then please get in touch.
